Immediate Impact

6 by Nobel laureates 4 from Science/Nature 71 standout
Sub-graph 1 of 22

Citing Papers

Soft Sensors and Actuators for Wearable Human–Machine Interfaces
2024 Standout
Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes
2024 Standout
2 intermediate papers

Works of Blessing Agunwamba being referenced

Survival, Response Duration, and Activity By Braf Mutation (Mt) Status in a Phase 1 Trial of Nivolumab (Anti-Pd-1, Bms-936558, Ono-4538) and Ipilimumab (Ipi) Concurrent Therapy in Advanced Melanoma (Mel)
2014
Survival, response duration, and activity by BRAF mutation (MT) status of nivolumab (NIVO, anti-PD-1, BMS-936558, ONO-4538) and ipilimumab (IPI) concurrent therapy in advanced melanoma (MEL).
2014

Author Peers

Author Last Decade Papers Cites
Blessing Agunwamba 88 214 2 134 5 261
Kangling Xu 78 129 5 173 5 303
Kun‐Hui Lu 184 146 142 8 311
R. Maragliano 97 161 4 73 5 273
Stefanie Riesenberg 186 98 1 98 6 285
Stine Emilie Weis-Banke 90 150 14 171 10 303
Mélanie Buchi 66 132 5 90 6 215
Dennis Clement 36 176 2 275 7 325
Marina Roy-Luzarraga 115 95 67 6 219
Andrew J. Wicks 241 256 40 5 325
Alexander Kirchmair 124 96 6 136 6 252

All Works

Loading papers...

Rankless by CCL
2026